×

Warning

JUser: :_load: Unable to load user with ID: 64

Monday, 31 December 2012 20:54

Most-read journal articles in 2012 by nephrologists

According to Medscape, 3 out of 10 of the most-read articles by nephrologists in 2012 are from Kidney International. See below.

A great way to end 2012 for our editorial team. Kudos to all of them, and we all wish 2013 will see even more achievements for KI.



1. Abnormal Urine Color
South Med J. 2012;105(1):43-47. © 2012 Lippincott Williams & Wilkins

2. Starting Dialysis Is Dangerous
Kidney Int. 2012;82(4):382-387. © 2012 Nature Publishing Group

3. The Changing Definition of Contrast-Induced Nephropathy and Its Clinical Implications
Am Heart J. 2012;163(5):829-834. © 2012 Mosby, Inc.

4. Prevalence of Hyperaldosteronism in Primary Care Patients With Resistant Hypertension
J Am Board Fam Med. 2012;25(1):98-103. © 2012 American Board of Family Medicine

5. Antihypertensive Drugs and Risk of Incident Gout Among Patients With Hypertension
BMJ © 2012 BMJ Publishing Group

6. Treatment of Chronic Kidney Disease
Kidney Int. 2012;81(4):351-362. © 2012 Nature Publishing Group

7. Risk of Pneumonia Associated With Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
BMJ © 2012 BMJ Publishing Group

8. Hepatorenal Syndrome
Am J Kidney Dis. 2012;59(6):874-885. © 2012 The National Kidney Foundation

9. Aldosterone Blockade and the Mineralocorticoid Receptor in the Management of Chronic Kidney Disease
Kidney Int. 2012;81(10):955-968. © 2012 Nature Publishing Group

10. What Is a Preferred Angiotensin II Receptor Blocker-based Combination Therapy for Blood Pressure Control in Hypertensive Patients With Diabetic and Non-diabetic Renal Impairment?
Cardiovasc Diabetol. 2012;11(32):1-12. © 2012 BioMed Central, Ltd.

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact